Comorbidities of COVID-19 patients

R Silaghi-Dumitrescu, I Patrascu, M Lehene, I Bercea - Medicina, 2023 - mdpi.com
The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible
for the coronavirus disease outbreak initiated in 2019 (COVID-19) has been shown to affect …

Exploring the potential of nanotechnology in pediatric healthcare: advances, challenges, and future directions

H Omidian, K Mfoafo - Pharmaceutics, 2023 - mdpi.com
The utilization of nanotechnology has brought about notable advancements in the field of
pediatric medicine, providing novel approaches for drug delivery, disease diagnosis, and …

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection

T Saha, S Sinha, R Harfoot, ME Quiñones-Mateu… - Pharmaceutics, 2023 - mdpi.com
There is a continuous effort to develop efficient treatments for coronavirus disease 2019
(COVID-19) and other viral respiratory diseases. Among the different strategies, inhaled …

Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors

V De Luca, A Angeli, A Nocentini, P Gratteri… - International Journal of …, 2024 - mdpi.com
The implementation of innovative approaches is crucial in an ongoing endeavor to mitigate
the impact of COVID-19 pandemic. The present study examines the strategic application of …

Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study

C Suffritti, R Gualtierotti, S Arcudi, A Ciavarella… - Journal of Clinical …, 2023 - mdpi.com
To characterize the immunogenicity of mRNA-1273 (Moderna, Cambridge, MA, USA)
vaccine in HIV-positive hemophilic patients during the third COVID-19 wave in Italy and to …